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Background: The role of sex on the response to therapy in ACS remains controversial.
Methods: We evaluated this in EARLY ACS, comparing early vs delayed eptifibatide in 9492 high-risk NSTE ACS pts (31% women) managed with an 
invasive strategy.
Results: Compared with men, women were older (median 71 vs. 66 y), more often diabetic (34 vs 29%), weighed less (70 vs 82 kg), had lower 
creatinine clearance (median 63 vs 80 ml/min) and less frequent troponin elevation at baseline (80 vs 86%); all p<0.001. Time from randomization 
to mechanical intervention & eptifibatide duration pre-PCI was similar, but women had less PCI (54 vs 62%, p<0.001) & more medical therapy 
alone (38 vs 24%, p<0.001). Non-obstructive CAD (<50% stenosis) was more prevalent in women (16 vs 6%, p<0.001), but this subgroup of women 
frequently exhibited high risk features (59% had ST changes, 64% elevated baseline troponin). Overall clinical benefit and major bleeding was 
similar but women had higher rates of transfusion (including non-CABG) (Table). After multivariable adjustment, women more often received non-
CABG-related transfusion.
Conclusions: Important sex differences exist in high-risk pts with NSTE ACS managed with an invasive strategy. In high-risk ACS 
women have ST changes & elevated troponin but less coronary disease. Despite these differences, the effect of treatment on ischemic 
& bleeding events is similar. A better understanding of these issues, particularly higher transfusion rates in women, is warranted. 
